Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Exclusive new insight into Multi-Organ-Chip Technology

SMi Group
Posted on: 21 Dec 17
Exclusive new insight into Multi-Organ-Chip Technology

Since 2010 Reyk Horland is actively involved in the development of TissUse’s Multi-Organ-Chip platform for culture analysis of drug candidates, cosmetics, chemicals and consumer products. In his exclusive interview with SMi Group he talks about current industry trends and his upcoming presentation at the 3D Cell Culture Conference, 21-22 February, London

 

Here is the extract from the interview, and you can find full version on the 3D Cell Culture Conference website http://www.3D-cellculture.com/prphiwjan

 

Q. Which area of research do you think has most benefited from 3D cell culture?

A. Safety as well as efficacy testing of new compounds has benefited a lot with the introduction of 3D cell culture models. In addition 3D cell culture models are traditionally employed in a variety of Tissue Engineering applications.

 

Q. What do you see as the greatest hurdle to 3D cell culture?

A. Standardization of 3D cell culture models is challenging as these models are usually more complex than their 2D counterparts. It is therefore important to establish robust SOPs which allow the translation and inter-laboratory validation of 3D models.

 

Q. What do you think has been the greatest innovation within 3D cell culture over the last year or two?

A. The huge increase of available 3D microphysiological systems capable of emulating organ functions at physiologically relevant levels.

 

Q. Where do you see 3D cell culture leading us over the next few years?

A. We should see a lot of applications in personalized medicine by either using iPS-derived models or patient derived cells.

 

Q. What do you hope to gain from the SMi’s 3D Cell Culture Conference?

A. I’m very much interested in learning more about attendees’ views and experience with 3D cell culture and Organ-on-a-Chip systems. I’m also looking forward to discussions on potential use and application of Organ-on-a-Chip systems.

 

There are other important questions and views Reyk Horland have raised during the interview, full version is available on 3D Cell Culture Conference website https://goo.gl/vZ1fUD

 

3D Cell Culture Conference will take place on 21 - 22 February 2018 at the Copthorne Tara Hotel, London, UK. Further information including a full speaker line-up and detailed agenda is available online at www.3D-cellculture.com/prphiwjan

 

3D Cell Culture Conference is sponsored by Bio-Techne, Integra Biosciences, Jellagen and Nexcelom

 

 

-----END----

 

Contact Information:

For media enquiries contact Lyudmyla Durneva on +44 (0) 207 827 6088 / LDurneva@smi-online.co.uk

For all other enquires contact the team on +44 (0)20 7827 6000 / events@smi-online.co.uk  

 

About SMi Group:

Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

For more information:
www.3D-cellculture.com/prphiwjan

Editor's Details

Lyudmyla Durneva
SMi Group
www.3D-cellculture.com/prphiwjan
+44 (0) 20 7827 6000
LDurneva@smi-online.co.uk

Last updated on: 21/12/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.